A Brandon scientist says the future of agricultural crop research in Canada will be focused on gene editing and trait study, ...

Two Nebraska researchers have launched a startup company aimed at bringing to market an innovative method for delivering therapeutics, gene editing tools, plasmids and more to targeted locations in ...

Craig-Hallum analyst Matt Hewitt maintained a Buy rating on MaxCyte (MXCT – Research Report) today. The company’s shares opened today at ...

In BlueAllele Corp. v. Intellia Therapeutics, Inc., 2024 U.S. Dist. Lexis 222094 (D. Del. Dec. 9, 2024)1, the District of ...

When four Eurasian lynxes were released illegally into the Scottish Highlands this month, it reignited a long-running debate: ...

The Colossal Foundation, the 501(c)(3) arm of Colossal BioSciences and a leading organization focused on pioneering ...

IntroductionThe global cancer therapeutics market is on an exponential growth trajectory, driven by advancements in treatment ...

In a rapidly advancing world a new wave of Chinese innovators are pushing the boundaries of science and technology These pioneers are not just imagi ...

Nebraska researchers introduce Minovacca, pioneering programmable milk exosomes for targeted therapeutic delivery, offering ...

Touchlight, an innovation-driven Contract Development and Manufacturing Organisation (CDMO), today announced that its facility in Hampton UK has received GMP certification. As a result, Touchlight ...

CRISPR gene-editing technology presents a possible solution for feeding a growing population, but incorporating CRISPR into ...

EYLEA HD® and EYLEA® remained the U.S. anti-VEGF category leader in 2024; aggregate U.S. net product sales were $6 billion for full-year 2024, up 1% based on preliminary (unaudited) results EYLEA HD ...